This trial is active, not recruiting.

Condition substance abuse
Sponsor George Mason University
Collaborator National Institute on Drug Abuse (NIDA)
Start date September 2009
End date July 2018
Trial size 250 participants
Trial identifier NCT01572441, 0909005677, R01DA033431


The purpose of this study is to observe parent-adolescent interactions and to examine the parenting behaviors and adolescent emotional and physiological responses that are associated with youth's substance use.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
No intervention administered. This is a longitudinal observational study including observation of behaviors and physiological responses.

Primary Outcomes

Substance Use
time frame: Baseline
Substance Use
time frame: 6 month follow-up
Substance Use
time frame: 1 year follow-up
Substance Use
time frame: 2 year follow-up
Substance Use
time frame: 3 year follow-up

Eligibility Criteria

All participants from 12 years up to 14 years old.

Inclusion Criteria: - Adolescent between ages 12-14 years Exclusion Criteria: - For adolescent, Intelligence Quotient (IQ) < 70 on standardized test, for parent, evidence of inability to read or write. - Evidence of a psychotic disorder for parent or adolescent - Diagnosis of autism or pervasive developmental disorder for adolescent, as determined by parent report in the screening. - For adolescent, current need for acute treatment of a psychiatric disorder, as determined by parent report in the study screening. - For adolescent and parent, inadequate English proficiency to comprehend task instructions

Additional Information

Official title Responses During Parent-child Interactions and Alcohol Use Behavior in Adolescents.
Principal investigator Tara Chaplin, Ph.D.
Description The study examines parenting behaviors and adolescent emotional responses during parent-adolescent interactions and whether these predict youth's current and future substance use over a 3 year follow-up.
Trial information was received from ClinicalTrials.gov and was last updated in February 2017.
Information provided to ClinicalTrials.gov by George Mason University.